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Background
Angiotensin converting enzyme-2 (ACE2) is an analogue
of the ACE that cleaves Angiotensin II to Angiotensin
1-7, a peptide with vasodilatory properties. Previous stu-
dies showed increased ACE2 activity among patients
with chronic heart failure. ACE2 activity has been
shown to correlate with the NYHA functional class in
this setting, suggesting a compensatory role in advanced
heart failure. The relationship between ACE2 activity
and myocardial function in patients with ST-elevation
acute myocardial infarction (STEMI) remains unknown.
Aim
We sought to explore the relationship between ACE2
activity, infarct size and acute left ventricular (LV) systo-
lic function following STEMI.
Methods
We prospectively included 44 patients with their first
STEMI reperfused by primary percutaneous interven-
tion. Baseline blood samples were drawn between 12
and 24 hs from admission and at 7 days. A standard
cine and contrast enhanced-cardiac magnetic resonance
study was performed during admission. LV end-diastolic
(LVED) and end-systolic (LVES) indexes, ejection frac-
tion (EF) and infarct size (expressed as % of the LV
mass), were computed by manual plannimetry on
sequential short axis cine and delayed enhanced images,
respectively. Serum ACE2 activity was measured by
fluorometric assay using a specific substrate.
Results
Baseline ACE2 activity did not correlate with LV volume
indexes, EF, infarct size and BNP. By paired analysis,
ACE2 activity significantly increased from baseline to 7
days in STEMI patients (104±66 to 126±84 RFU/µl/hr,
p<0.02). Furthermore, at 7 days a significant direct
correlation was observed between ACE2 activity and all,
LVES index (r=0.41, p<0.02), infarct size (r=0.34,
p<0.05) and baseline BNP levels (r=0.36, p<0.05).
Additionally, a significant inverse correlation between
ACE2 activity and EF was observed (r=-0.39, p<0.01).
See figure.
Conclusion
ACE2 serum activity rises during the first week follow-
ing STEMI and the increase is related to infarct size and
underlying indicators of LV systolic dysfunction. As sug-
gested in chronic heart failure stages, ACE2 activation
may reflect a compensatory mechanism to limit left ven-
tricular dysfunction and could potentially indicate a new
target for therapy following STEMI reperfusion.
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